Clinical Trials Logo

Refractory Partial Seizures clinical trials

View clinical trials related to Refractory Partial Seizures.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04558580 Withdrawn - Clinical trials for Refractory Partial Seizures

Safety Study of Rufinamide Given as an add-on Therapy to Treat Patients With Seizures

Start date: April 2006
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of Rufinamide in reducing seizure frequency in subjects with partial seizures not fully controlled despite treatment with 1 to 3 concomitant antiepileptic drugs.